Financial Enhancement Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-18,877
Closed -$3.32M – 231
2022
Q3
$3.32M Sell
18,877
-15,430
-45% -$3.16M 0.77% 32
2022
Q2
$6.91M Buy
34,307
+3,771
+12% +$804K 1.49% 17
2022
Q1
$6.92M Sell
30,536
-7,071
-19% -$1.66M 1.28% 22
2021
Q4
$10.2M Buy
37,607
+1,086
+3% +$269K 1.78% 16
2021
Q3
$8.83M Buy
36,521
+3,254
+10% +$820K 1.67% 18
2021
Q2
$7.88M Sell
33,267
-1,105
-3% -$252K 1.62% 19
2021
Q1
$7.53M Buy
+34,372
New +$6.9M 1.54% 22

Other funds holding LH

Financial Enhancement Group's LH Position: Q4 2022 in Review

Financial Enhancement Group sold out of Labcorp (LH) in Q4 2022, closing a stake of 18,877 shares — an estimated $3.32M sold.

Financial Enhancement Group first reported a position in LH in Q1 2021 and held it in 7 quarters. The position peaked at $10.2M in Q4 2021. 969 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Financial Enhancement Group reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Financial Enhancement Group sold 18,877 Labcorp shares in Q4 2022, an estimated $3.32M.
  • Financial Enhancement Group first reported a position in Labcorp in Q1 2021 and held it in 7 quarters.
  • Financial Enhancement Group's Labcorp position peaked at $10.2M in Q4 2021.
  • 969 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.